LIGAND PHARMACEUTICALS INC's ticker is and the CUSIP is 53220KAD0. A total of 26 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $4,137,000 | – | 2,500,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| LINDEN ADVISORS LP | 57,915,000 | $89,697,000 | 5.40% |
| Man Investments (CH) AG | 4,000,000 | $6,224,000 | 2.47% |
| CAMDEN ASSET MANAGEMENT L P /CA | 38,150,000 | $58,846,000 | 1.85% |
| BASSO CAPITAL MANAGEMENT, L.P. | 7,720,000 | $11,947,000 | 1.77% |
| WOLVERINE ASSET MANAGEMENT LLC | 24,445,000 | $37,808,000 | 0.81% |
| CSS LLC/IL | 4,000,000 | $6,192,000 | 0.37% |
| PALISADE CAPITAL MANAGEMENT, LP | 4,800,000 | $7,440,000 | 0.24% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 3,922,000 | $6,193,000 | 0.10% |
| Calamos Advisors LLC | 7,000,000 | $10,893,000 | 0.07% |
| LAZARD ASSET MANAGEMENT LLC | 17,200,000 | $26,617,000 | 0.06% |